Tweet Of The Week: Ex-BT PR Adam Liversage On Phorm

0 Comments

This was the week BT (NYSE: BT), after trialling with Phorm, finally distanced itself from the on-ISP behavioural advertising company. Adam Liversage, who was until recently BT’s chief press officer, had this to say

Comments are closed.